BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013

Nov 13, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-11-12

Reporting Person: ABERCROMBIE GEORGE B (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-12	Common Stock	P	3000	$6.19	Acquired	6000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.18 to $6.19, inclusive. The reporting person undertakes to provide to BioCryst Pharmaceuticals, Inc., any security holder of BioCryst Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.